Uterine Cervical Lesions
Conditions
Interventions
Training group:None
Validation group:None
Sponsors
People’s Hospital of Ningxia Hui Autonomous Region
Eligibility
Sex/Gender
Female
Age
35 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Females aged 35-64 years with a history of sexual life. 2. The initial hrHPV DNA test in the clinic is positive, and the remaining cell samples for hrHPV testing can be collected. 3. Sign the informed consent form, be willing and able to accept colposcopy, and have histological results that meet the diagnostic criteria, if needed. 4. No history of cervical cancer and precancerous lesions treatment.
Exclusion criteria
Exclusion criteria: 1. Pregnant women; 2. Women with immunodeficiency; 3. Women with a history of other gynecological malignancies and tumors; 4. Women with incomplete personal information: sample collection unit, name, age, cytology test results, HPV test results, colposcopy pathology results, cytology history within 5 years, and history of colposcopy within 5 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DNA methylation;Diagnosis proportion of CIN2+; | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnosis proportion of CIN3+; | — |
Countries
China
Contacts
Public ContactYang Fan
People’s Hospital of Ningxia Hui Autonomous Region
Outcome results
None listed